ScoreWhy is Zydus Lifesciences Ltd ?
1
Negative results in Dec 25
- INTEREST(Latest six months) At Rs 231.20 cr has Grown at 43.34%
- OPERATING PROFIT TO INTEREST(Q) Lowest at 13.98 times
- ROCE(HY) Lowest at 20.07%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Zydus Lifesci. for you?
Low Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Zydus Lifesci.
-2.99%
-0.14
21.67%
Sensex
-2.38%
-0.19
12.70%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.37%
EBIT Growth (5y)
22.94%
EBIT to Interest (avg)
32.74
Debt to EBITDA (avg)
0.71
Net Debt to Equity (avg)
0.10
Sales to Capital Employed (avg)
0.85
Tax Ratio
25.62%
Dividend Payout Ratio
7.82%
Pledged Shares
0
Institutional Holding
18.15%
ROCE (avg)
20.77%
ROE (avg)
17.34%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
17
Industry P/E
31
Price to Book Value
3.54
EV to EBIT
13.34
EV to EBITDA
11.46
EV to Capital Employed
3.31
EV to Sales
3.53
PEG Ratio
1.20
Dividend Yield
1.24%
ROCE (Latest)
23.72%
ROE (Latest)
20.19%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
PAT(Latest six months)
At Rs 2,386.24 cr has Grown at 23.34%
NET SALES(Q)
At Rs 6,864.50 cr has Grown at 30.28%
-19What is not working for the Company
INTEREST(Latest six months)
At Rs 231.20 cr has Grown at 43.34%
OPERATING PROFIT TO INTEREST(Q)
Lowest at 13.98 times
ROCE(HY)
Lowest at 20.07%
DEBT-EQUITY RATIO(HY)
Highest at 0.38 times
Loading Valuation Snapshot...
Here's what is working for Zydus Lifesci.
Profit After Tax (PAT) - Latest six months
At Rs 2,386.24 cr has Grown at 23.34%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 6,864.50 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 6,864.50 cr has Grown at 30.28%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Zydus Lifesci.
Operating Profit to Interest - Quarterly
Lowest at 13.98 times and Fallen
each quarter in the last five quartersMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Interest - Quarterly
At Rs 129.90 cr has Grown at 28.23%
Quarter on Quarter (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Interest - Quarterly
Highest at Rs 129.90 cr
in the last five quarters and Increased by 28.23 % (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Debt-Equity Ratio - Half Yearly
Highest at 0.38 times
in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
